U.S. Constellation Alpha Capital to buy drugmaker DermTech in $15 mln deal

03/18/2019 3:56:00 PM (GMT)

U.S.-based special purpose acquisition company Constellation Alpha Capital has inked an agreement to buy biotechnology company DermTech.

Under the pact, Constellation Alpha Capital will pay about $15 million for DermTech.

As part of the deal, DermTech will become a unit of Constellation in exchange for shares of Constellation common stock.

The transaction is expected to be completed in the second quarter.

Constellation Alpha Capital

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text